These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6355974)

  • 21. [Antibodies against Escherichia coli in ulcerous colitis].
    Anselm K; LoGrippo GA; Hayashi H
    Z Gastroenterol; 1971; 9(9):648-50. PubMed ID: 4949181
    [No Abstract]   [Full Text] [Related]  

  • 22. [Extraction of soluble antigens from Candida albicans by means of hypertonic salt solution (3M KCl)].
    Marconi P; Bistoni F; Boncio L; Bersiani A; Pitzurra M
    Boll Soc Ital Biol Sper; 1975 Oct; 51(20):1432-5. PubMed ID: 782486
    [No Abstract]   [Full Text] [Related]  

  • 23. Enteropathogenic Escherichia coli and ulcerative colitis in cotton-top tamarins (Saguinus oedipus).
    Mansfield KG; Lin KC; Xia D; Newman JV; Schauer DB; MacKey J; Lackner AA; Carville A
    J Infect Dis; 2001 Sep; 184(6):803-7. PubMed ID: 11517446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intestinal microflora in the stools of patients with ulcerative colitis].
    Dolezalowa M; Starzecka B
    Przegl Epidemiol; 1965; 19(2):174-5. PubMed ID: 5327544
    [No Abstract]   [Full Text] [Related]  

  • 25. Autoantibodies to colon in rats and human ulcerative colitis: cross reactivity with Escherichia coli O:14 antigen.
    Perlmann P; Hammarström S; Lagercrantz R; Campbell D
    Proc Soc Exp Biol Med; 1967 Jul; 125(3):975-80. PubMed ID: 15938314
    [No Abstract]   [Full Text] [Related]  

  • 26. [The bacteriological and immunological efficacy of biosporin in nonspecific ulcerative colitis].
    Cherniakova VI; Bereza NM; Selezneva SI; Chaplinskiĭ VIa; Kudriavtseva VE; Mosalova NM; Shevtsova ZI; Tropko LV; Boĭko TI
    Mikrobiol Zh (1978); 1993; 55(3):63-7. PubMed ID: 8355632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactivity in vitro of lymphocytes from patients with ulcerative colitis.
    Hinz CF; Perlmann P; Hammarström S
    J Lab Clin Med; 1967 Nov; 70(5):752-9. PubMed ID: 4861750
    [No Abstract]   [Full Text] [Related]  

  • 28. [Allergic syndrome in intestinal diseases and efficacy of specific bacterial immunotherapy].
    Nogaller AM; Malygin AG; Molotilov BA
    Ter Arkh; 1981; 53(10):79-83. PubMed ID: 7313969
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa.
    Zwolinska-Wcislo M; Brzozowski T; Budak A; Kwiecien S; Sliwowski Z; Drozdowicz D; Trojanowska D; Rudnicka-Sosin L; Mach T; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2009 Mar; 60(1):107-18. PubMed ID: 19439813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased incidence of faecal coliforms with in vitro adhesive and invasive properties in patients with ulcerative colitis.
    Dickinson RJ; Varian SA; Axon AT; Cooke EM
    Gut; 1980 Sep; 21(9):787-92. PubMed ID: 7000634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intestinal bacterial microflora study in chronic ulcerohemorrhagic colitis].
    Kozareva M; Nedkova-Bratanova N; Enikova R; Stoiano Z; Boneva M
    Vutr Boles; 1981; 20(3):58-63. PubMed ID: 6973892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clostridium difficile in the feces in acute diarrhea, irritable colon and ulcerative colitis].
    Willumsen L; Tvede M
    Ugeskr Laeger; 1983 Mar; 145(12):902-4. PubMed ID: 6857791
    [No Abstract]   [Full Text] [Related]  

  • 33. [Intestinal microflora in patients with nonspecific ulcerative colitis].
    Kosumian VKh; Kosumian TP
    Klin Med (Mosk); 1983 Jun; 61(6):72-4. PubMed ID: 6350701
    [No Abstract]   [Full Text] [Related]  

  • 34. Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3.
    Jawhara S; Thuru X; Standaert-Vitse A; Jouault T; Mordon S; Sendid B; Desreumaux P; Poulain D
    J Infect Dis; 2008 Apr; 197(7):972-80. PubMed ID: 18419533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defects in mucosal immunity leading to ulcerative colitis.
    Targan SR; Karp LC
    Immunol Rev; 2005 Aug; 206():296-305. PubMed ID: 16048556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutritional therapies for ulcerative colitis: literature review, chart review study, and future research.
    Edman JS; Williams WH; Atkins RC
    Altern Ther Health Med; 2000 Jan; 6(1):55-63. PubMed ID: 10631823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Induction of autologous tissue disorders in animals tolerant to cross-reacting microbial antigens].
    Ogurtsov RP
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Jun; (6):52-6. PubMed ID: 1098337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Should every patient with ulcerative colitis/Crohn disease be vaccinated against pneumococcal infection?].
    Moum B
    Tidsskr Nor Laegeforen; 1997 Sep; 117(22):3262-3. PubMed ID: 9411871
    [No Abstract]   [Full Text] [Related]  

  • 39. [The grouping of torulopsis species according to the Salmonella cholerae-suis O 6,7 antigens. 3. Communication (author's transl)].
    Aksoycan N
    Zentralbl Bakteriol Orig A; 1977 Dec; 239(4):554-6. PubMed ID: 76381
    [No Abstract]   [Full Text] [Related]  

  • 40. [Microbiological etiopathogenesis of ulcerative colitis].
    WAGNER V
    Cas Lek Cesk; 1957 Sep; 96(38):1190-3. PubMed ID: 13489736
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.